Huateng Pharma offers high-end biological high-tech enterprise certification, chemical reagents & APIs.
Hunan Huateng Pharmaceutical Co., Ltd is a company committed to research and development, production and sales of high-end PEG derivatives and products used across the pharmaceutical value chain including intermediates, excipients, APIs, and reagents. Huateng pharmaceuticals in Chinese, European and American countries have our own R & D and logistics center, the company has an excellent and efficient R & D and production and sales of a professional team. Fast for all global customers to provide professional, personalized and technical support of the one-stop service, can rapid and efficient delivery of products to the customers all around the world.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 27, 2019 | Series A | ¥50M | 3 | Boyi Fund | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Boyi Fund | Yes | Series A |
Dingteng Juzhi Investment | — | Series A |
Zhudan Equity Investment Fund | — | Series A |